• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Subject of the year: who are we missing, who are we overtreating, and who is best served? Refining the prescription of implantable cardioverter-defibrillator therapy.

作者信息

Epstein Andrew E

出版信息

J Interv Card Electrophysiol. 2009 Nov;26(2):91-4. doi: 10.1007/s10840-009-9439-y.

DOI:10.1007/s10840-009-9439-y
PMID:19904594
Abstract
摘要

相似文献

1
Subject of the year: who are we missing, who are we overtreating, and who is best served? Refining the prescription of implantable cardioverter-defibrillator therapy.年度主题：我们遗漏了谁，谁接受了过度治疗，谁得到了最佳治疗？优化植入式心脏复律除颤器治疗的处方
J Interv Card Electrophysiol. 2009 Nov;26(2):91-4. doi: 10.1007/s10840-009-9439-y.
2
Implantable cardioverter-defibrillators: is there life after death?植入式心脏复律除颤器：“死后”还有生机吗？
Pacing Clin Electrophysiol. 2013 Jan;36(1):2-6. doi: 10.1111/pace.12023. Epub 2012 Oct 27.
3
Association of Implantable Cardioverter Defibrillator Therapy with All-Cause Mortality-A Systematic Review and Meta-Analysis.植入式心脏复律除颤器治疗与全因死亡率的关联——一项系统评价和荟萃分析
Pacing Clin Electrophysiol. 2016 Jan;39(1):81-8. doi: 10.1111/pace.12766. Epub 2015 Nov 19.
4
The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.植入式心脏复律除颤器患者中的性别悖论：一项倾向匹配研究。
Pacing Clin Electrophysiol. 2013 Jul;36(7):878-84. doi: 10.1111/pace.12141. Epub 2013 Apr 24.
5
[ICD therapy as secondary prevention].[植入式心律转复除颤器治疗作为二级预防]
Herzschrittmacherther Elektrophysiol. 2010 Jun;21(2):96-101. doi: 10.1007/s00399-010-0075-0.
6
The epidemiology and costs of implantable cardioverter-defibrillator therapy in Australia.澳大利亚植入式心脏复律除颤器治疗的流行病学及成本
Med J Aust. 2018 Aug 6;209(3):116-117. doi: 10.5694/mja18.00601.
7
Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government.对植入式除颤器治疗无反应的心脏性猝死：临床医生、行业和政府的紧迫目标。
J Interv Card Electrophysiol. 2005 Nov;14(2):71-8. doi: 10.1007/s10840-005-4547-9.
8
Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More.为什么我们必须更多地使用心脏再同步治疗起搏器。
Card Electrophysiol Clin. 2015 Dec;7(4):709-20. doi: 10.1016/j.ccep.2015.08.016.
9
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.女性使用除颤器治疗的一级预防：心力衰竭试验中心脏性猝死的结果。
J Cardiovasc Electrophysiol. 2008 Jul;19(7):720-4. doi: 10.1111/j.1540-8167.2008.01129.x. Epub 2008 Mar 26.
10
[Risk stratification for sudden cardiac death].[心脏性猝死的风险分层]
Herzschrittmacherther Elektrophysiol. 2015 Mar;26(1):3-4. doi: 10.1007/s00399-015-0356-8.

引用本文的文献

1
Efficacy and safety of implantable cardioverter-defibrillator implantation in the elderly-The I-70 Study: A randomized clinical trial.植入式心脏复律除颤器植入术在老年人中的疗效与安全性——I-70研究：一项随机临床试验
Heart Rhythm O2. 2024 Apr 27;5(6):365-373. doi: 10.1016/j.hroo.2024.04.010. eCollection 2024 Jun.

本文引用的文献

1
Implantable cardioverter-defibrillator prescription in the elderly.老年患者植入式心律转复除颤器的处方
Heart Rhythm. 2009 Aug;6(8):1136-43. doi: 10.1016/j.hrthm.2009.04.010. Epub 2009 Apr 10.
2
Ethnic and racial disparities in cardiac resynchronization therapy.心脏再同步治疗中的种族差异
Heart Rhythm. 2009 Mar;6(3):325-31. doi: 10.1016/j.hrthm.2008.12.018. Epub 2008 Dec 13.
3
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
《2009年心脏病和中风统计数据更新：美国心脏协会统计委员会及中风统计小组委员会报告》
Circulation. 2009 Jan 27;119(3):e21-181. doi: 10.1161/CIRCULATIONAHA.108.191261. Epub 2008 Dec 15.
4
Benefits of the implantable cardioverter-defibrillator.植入式心脏复律除颤器的益处。
J Am Coll Cardiol. 2008 Sep 30;52(14):1122-7. doi: 10.1016/j.jacc.2008.06.035.
5
A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.对植入式心脏复律除颤器预防心源性猝死治疗的批判性评价。
J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058.
6
Age and gender trends in implantable cardioverter defibrillator utilization: a population based study.植入式心脏复律除颤器使用情况的年龄和性别趋势：一项基于人群的研究。
J Interv Card Electrophysiol. 2008 Jun;22(1):65-70. doi: 10.1007/s10840-008-9213-6. Epub 2008 Mar 7.
7
Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.缺血性左心室功能不全患者植入心脏复律除颤器的风险分层
J Am Coll Cardiol. 2008 Jan 22;51(3):288-96. doi: 10.1016/j.jacc.2007.08.058.
8
Disparities in use of implantable cardioverter-defibrillators: moving beyond process measures to outcomes data.
JAMA. 2007 Oct 3;298(13):1564-6. doi: 10.1001/jama.298.13.1564.
9
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.心力衰竭住院患者植入式心脏复律除颤器使用中的性别和种族差异。
JAMA. 2007 Oct 3;298(13):1525-32. doi: 10.1001/jama.298.13.1525.
10
Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.用于心脏性猝死一级和二级预防的植入式心律转复除颤器使用中的性别差异。
JAMA. 2007 Oct 3;298(13):1517-24. doi: 10.1001/jama.298.13.1517.